
ARE Stock Forecast & Price Target
ARE Analyst Ratings
Bulls say
Alexandria Real Estate is positioned to capitalize on strong long-term life science tailwinds thanks to its focus on providing space for lease to tenants in the industry. The company's strong market position in key locations and its partnerships in developing properties for the life science industry contribute to its potential for growth in the future. Their commitment to sustainability and focus on development opportunities are additional factors that could drive earnings growth.
Bears say
Alexandria Real Estate is facing a challenging outlook as the company is re-evaluating its development strategy and selling assets in an effort to reduce capex costs and earn revenue earlier than previously expected. Additionally, the soft life science real estate market and uncertainty surrounding the biotechnology sector could further weigh on the company's earnings and potentially disrupt operations. While the company has a record backlog and potential for long-term growth, macro headwinds and project delays could have a significant impact on future earnings. Given these factors, the company's stock may continue to face downward pressure, and a cautious approach is warranted when considering an investment.
This aggregate rating is based on analysts' research of Alexandria Real Estate Equities and is not a guaranteed prediction by Public.com or investment advice.
ARE Analyst Forecast & Price Prediction
Start investing in ARE
Order type
Buy in
Order amount
Est. shares
0 shares